Currently Viewing:
Newsroom
Currently Reading
What We're Reading: Surprise Ambulance Bills; Brexit's Health Impact; Antibiotic Resistance Threat
November 24, 2017 – AJMC Staff
This Week in Managed Care: November 24, 2017
November 24, 2017
AJMC® in the Press, November 22, 2017
November 24, 2017 – AJMC Staff
Systolic Blood Pressure of 140 mm Hg or Higher Should Be Treated to Prevent Death and CVD
November 23, 2017 – Jaime Rosenberg
What We're Reading: End-of-Life Discussions; New Opioid Guidance; Missouri's HCV Drug Policy
November 23, 2017 – AJMC Staff
Roche Sues Pfizer to Block Its Biosimilar Referencing Herceptin
November 22, 2017 – Jaime Rosenberg
Consequences and Outcomes of Consolidation in Dermatology Driven by Private Investors
November 22, 2017 – AJMC Staff
Dr David Dale on Neutropenia: Symptoms, Causes, Dangers, and Costs
November 22, 2017 – Jaime Rosenberg
What We're Reading: Mass. Medicaid Drug Coverage; Disability Benefits Backlog; Real-World Data Collection
November 22, 2017 – AJMC Staff

Pneumococcal Vaccine Aids Young and Elderly Alike

Hospitalizations for to pneumococcal disease have been reduced since the introduction of the 7-valent vaccine (PCV7). The PCV7 vaccine has no only helped children, but the elderly as well.
Hospitalizations for to pneumococcal disease have been reduced since the introduction of the 7-valent vaccine (PCV7). The PCV7 vaccine has no only helped children, but the elderly as well. Contemporary Pediatrics reports:


In the 10 years following the introduction of 7-valent pneumococcal conjugate vaccine (PCV7), hospitalizations for pneumococcal disease have been and remain drastically reduced, not just for children but also for adults and particularly for the elderly, according to a new report.

Using a nationwide inpatient sample database, researchers from Vanderbilt University and the Centers for Disease Control and Prevention (CDC) looked at rates of pneumonia-related hospitalizations during the periods 1997 to 1999, before the introduction of the vaccine, and 2007 to 2009, well after the introduction of PCV7 in 2000, but before the switch to 13-valent pneumococcal conjugate vaccine (PCV13) in 2010.

Overall, in all age groups, the investigators calculated a 10.5% reduction in hospitalizations for pneumonia.

Read the full story: http://bit.ly/1dELpOw

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!